S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
New CBOE “special perk” helps traders target income every weekend (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
New CBOE “special perk” helps traders target income every weekend (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
New CBOE “special perk” helps traders target income every weekend (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
New CBOE “special perk” helps traders target income every weekend (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?

Virpax Pharmaceuticals Stock Price, News & Analysis (NASDAQ:VRPX)

$0.44
+0.05 (+12.66%)
(As of 12/4/2023 ET)
Compare
Today's Range
$0.38
$0.45
50-Day Range
$0.39
$0.82
52-Week Range
$0.32
$1.20
Volume
697,206 shs
Average Volume
35,803 shs
Market Capitalization
$5.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

VRPX stock logo

About Virpax Pharmaceuticals Stock (NASDAQ:VRPX)

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.

VRPX Stock Price History

VRPX Stock News Headlines

VRPX Virpax Pharmaceuticals, Inc.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Virpax Pharmaceuticals Announces Leadership Transition
Virpax Pharmaceuticals GAAP EPS of -$0.51
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Maxim Group Remains a Buy on Virpax Pharmaceuticals (VRPX)
Virpax Pharmaceuticals Announces CFO Transition
See More Headlines
Receive VRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
12/04/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
3/27/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:VRPX
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

Net Income
$-21,650,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.42 per share

Miscellaneous

Free Float
8,176,000
Market Cap
$5.21 million
Optionable
Not Optionable
Beta
1.48
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Anthony P. Mack M.B.A.Mr. Anthony P. Mack M.B.A. (Age 61)
    Chairman & CEO
    Comp: $705k
  • Dr. Jeffrey A. Gudin M.D. (Age 57)
    Executive VP, Chief Medical Officer & Director
    Comp: $204k
  • Mr. Gerald W. Bruce (Age 66)
    Executive VP of Commercial Operations & Director
  • Mr. Vinay Shah A.C.A. (Age 61)
    M.B.A., CFO, Principal Financial Officer & Principal Accounting Officer
  • Dr. Sheila A. Mathias J.D.
    M.B.A., Ph.D., Chief Scientific Officer
  • Shana Panzarella
    Chief of Staff














VRPX Stock Analysis - Frequently Asked Questions

How have VRPX shares performed in 2023?

Virpax Pharmaceuticals' stock was trading at $0.6223 at the beginning of the year. Since then, VRPX stock has decreased by 28.5% and is now trading at $0.4450.
View the best growth stocks for 2023 here
.

When is Virpax Pharmaceuticals' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our VRPX earnings forecast
.

When did Virpax Pharmaceuticals IPO?

(VRPX) raised $15 million in an IPO on Wednesday, February 17th 2021. The company issued 1,400,000 shares at $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Who are Virpax Pharmaceuticals' major shareholders?

Virpax Pharmaceuticals' stock is owned by many different institutional and retail investors. Top institutional investors include Sabby Management LLC (2.50%). Insiders that own company stock include Anthony P Mack, Eric Floyd, Jerrold Sendrow and Thani Jambulingam.
View institutional ownership trends
.

How do I buy shares of Virpax Pharmaceuticals?

Shares of VRPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:VRPX) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -